PKI 14-22 amide,myristoylated, CAS [[201422-03-9]]

Produktübersicht

• Artikelname: PKI 14-22 amide,myristoylated, CAS [[201422-03-9]]
• Artikelnummer: MCE-HY-P1291
• Hersteller Artikelnummer: HY-P1291
• Alternativnummer: MCE-HY-P1291-1MG,MCE-HY-P1291-5MG
• Hersteller: MedchemExpress
• Kategorie: Proteine/Peptide

Produktbeschreibung

PKI 14-22 amide, myristoylated is a selective, cAMP-dependent, competitive PKA inhibitor with Ki=~36 nM. The myristoylation modification of PKI 14-22 amide, myristoylated makes it more permeable to cell membranes and blood-brain barriers than the precursor molecule. PKI 14-22 amide, myristoylated can block the phosphorylation of cAMP-dependent downstream targets (such as CREB). PKI 14-22 amide, myristoylated can prevent the development of morphine analgesic tolerance in mice, and also inhibits protein translation and negative-strand RNA synthesis of Zika virus. PKI 14-22 amide, myristoylated can be used in research fields such as opioid tolerance mechanisms and antiviral drugs[1][2][3].

Produkteigenschaften

• Molekulargewicht: 1209.49
• Reinheit: 99.65
• CAS Nummer: [201422-03-9]
• Formel: C53H100N20O12
• Target-Kategorie: Epigenetic Reader Domain,Flavivirus,PKA

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Peptides